Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated Megakaryocytopoiesis by Tong, Wei & Lodish, Harvey F.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 
©
 
 The Rockefeller University Press • 0022-1007/2004/09/569/12 $8.00
Volume 200, Number 5, September 6, 2004 569–580
http://www.jem.org/cgi/doi/10.1084/jem.20040762
 
569
 
Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated 
Megakaryocytopoiesis
 
Wei Tong
 
1
 
 and Harvey F. Lodish
 
1,2
 
1
 
Whitehead Institute for Biomedical Research, Cambridge, MA 02142
 
2
 
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
 
Abstract
 
Thrombopoietin (Tpo) is the primary cytokine regulating megakaryocyte development and
platelet production. Tpo signaling through its receptor, c-mpl, activates multiple pathways
including signal transducer and activator of transcription (STAT)3, STAT5, phosphoinositide
3-kinase–Akt, and p42/44 mitogen-activated protein kinase (MAPK). The adaptor protein
Lnk is implicated in cytokine receptor and immunoreceptor signaling. Here, we show that Lnk
overexpression negatively regulates Tpo-mediated cell proliferation and endomitosis in hemato-
poietic cell lines and primary hematopoietic cells. Lnk attenuates Tpo-induced S-phase pro-
gression in 32D cells expressing mpl, and Lnk decreases Tpo-dependent megakaryocyte
growth in bone marrow (BM)–derived megakaryocyte culture. Consistent with this result, we
found that in both BM and spleen, Lnk-deficient mice exhibited increased numbers of mega-
karyocytes with increased ploidy compared with wild-type mice. In addition, Lnk-deficient
megakaryocytes derived from BM and spleen showed enhanced sensitivity to Tpo during cul-
ture. The absence of Lnk caused enhanced and prolonged Tpo induction of STAT3, STAT5,
Akt, and MAPK signaling pathways in CD41
 
 
 
 megakaryocytes. Furthermore, the Src homol-
ogy 2 domain of Lnk is essential for Lnk’s inhibitory function. In contrast, the conserved tyro-
sine near the COOH terminus is dispensable and the pleckstrin homology domain of Lnk
contributes to, but is not essential for, inhibiting Tpo-dependent 32D cell growth or mega-
karyocyte development. Thus, Lnk negatively modulates mpl signaling pathways and is impor-
tant for Tpo-mediated megakaryocytopoiesis in vivo.
Key words: hematopoiesis • megakaryocytes • cytokine receptors • 
cell proliferation • endomitosis
 
Introduction
 
Thrombopoietin (Tpo), the primary cytokine regulating
megakaryocyte development and platelet production, signals
through the mpl receptor (1, 2). Both Tpo
 
   
 
 and mpl
 
   
 
mice are severely thrombocytopenic with 10–15% of the
normal platelet levels (3, 4). In addition, Tpo and mpl
nullizygous mice exhibit markedly reduced megakaryocyte
and CFU-megakaryocyte progenitor numbers as well as
decreased  megakaryocyte ploidy (5). Interestingly, in the
absence of Tpo or mpl, the residual megakaryocytes and
platelets are morphologically and functionally normal (6, 7).
Therefore, Tpo/mpl is important for controlling megakary-
ocyte numbers by promoting their survival and/or prolifer-
ation as well as differentiation, but is not essential for mega-
karyocyte cytoplasmic maturation or platelet formation.
Mpl belongs to the type I cytokine receptor family,
which includes the erythropoietin receptor, growth hor-
mone receptor, and prolactin receptor. They share homol-
ogy in the membrane proximal region, which includes the
Box1 and Box2 domains (8). Ligand binding induces acti-
vation of the JAK2 that is associated with the receptor
through Box1 and Box2 (9). JAK2-deficient fetal livers fail
to respond to Tpo in forming megakaryocyte colonies,
which reveals its essential role in mpl signaling (10).
Activated JAK2 phosphorylates tyrosine residues on cy-
tokine receptors, thereby providing docking sites for several
Src homology 2 (SH2) domain–containing downstream
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signaling proteins. Mpl activates many signaling pathways
in hematopoietic cell lines and primary megakaryocytes
and platelets, including STAT3 and 5, Shc–Ras–mitogen-
activated protein kinase (MAPK), and SHP2–Gab–phos-
phoinositide-3 kinase–Akt pathways (2). These signaling
molecules have important roles in hematopoiesis, and
dysregulation of these signaling pathways is implicated in
leukemogenesis. STAT5a5b nullizygous mice exhibit
cytopenias affecting multiple peripheral blood lineages,
including reduced platelet numbers (11). Increased apop-
tosis, rather than decreased cell proliferation, accounts for
the intrinsic defect in early progenitors and stem cells ob-
served in STAT5a
 
   
 
5b
 
   
 
 mice (12). In addition, massive
apoptosis due to the lack of STAT5 blocks terminal my-
eloid differentiation (13).
Transgenic overexpression of a dominant negative form
of STAT3 did not affect megakaryocytopoiesis or throm-
bopoiesis; however, platelet recovery from myelosuppres-
sion after 5-fluorouracil treatment was significantly delayed
(14). These data indicate that STAT3 is dispensable for
megakaryocyte and platelet development, but is required
for effective expansion of early megakaryocyte progenitors.
The phosphoinositide 3-kinase–Akt pathway is necessary,
but not sufficient, for Tpo-induced proliferation of
megakaryocytic progenitors (15), and the p42/p44–MAPK
pathway is important for Tpo-induced endomitosis in pri-
mary megakaryocytes (16).
Lnk is a member of a newly discovered adaptor protein
family that also contains APS and SH2-B. These three share
common interaction domains: a proline-rich amino-termi-
nus, a pleckstrin homology (PH) domain, an SH2 domain,
and a conserved tyrosine near the carboxyl-terminus (17).
Mice nullizygous for Lnk revealed an essential role for Lnk
in B cell lymphopoiesis (18). The expansion of pro–/pre–
and immature B cells in Lnk
 
   
 
 mice is due to hyperpro-
liferation of immature B cells (18). In the absence of
Lnk, BM-derived cells are hypersensitive to stem cell factor
(SCF) activation, confirming that Lnk normally negatively
regulates c-Kit signaling pathways in immature B cells. In-
deed, Lnk becomes phosphorylated and interacts with c-Kit
upon SCF binding (19). Lnk nullizygous mice on a Kit
 
W/
 
 
 
background exhibit marginally restored B cell abnormalities,
supporting the notion that Lnk negatively regulates the
SCF–c-Kit signaling pathway (19). Overexpression of Lnk
in aorta-gonad-mesonephros (AGM) primary cultures sup-
presses the emergence of CD45
 
 
 
 hematopoietic cells via in-
hibition of the SCF–c-Kit signaling pathways (20).
In addition to lymphoid and AGM region developmen-
tal defects, Lnk-deficient mice also display a fivefold eleva-
tion of circulating platelets (21). Significant increased cell
numbers of the megakaryocytic and erythroid lineages as
well as increased B cells account for the splenomegaly in
the Lnk-deficient mice (21). Megakaryocytic (CFU-Meg)
progenitor numbers are significantly increased in the spleens
of Lnk
 
   
 
 mice, and the colony sizes derived from those
Lnk-deficient progenitor cells are significantly larger than
WT controls (21). This indicates that Lnk-deficient he-
matopoietic progenitor cells are hypersensitive to the growth-
promoting effects of several cytokines. Moreover, the
absence of Lnk causes abnormal modulation of IL-3 and
SCF–c-Kit signaling pathways (21). However, whether
Lnk directly modulates Tpo–mpl-mediated signaling path-
way has not been reported.
Here, we studied the function of Lnk in Tpo-mediated
signaling. We showed that overexpression of Lnk inhibits
Tpo-induced cell proliferation in the hematopoietic pro-
genitor cell line, 32D, by blocking cell cycle progression.
Lnk attenuates the sustained STAT5 and p42/44MAPK ac-
tivation normally observed after Tpo stimulation. We fur-
ther investigated the role of Lnk in primary hematopoietic
cells. Lnk overexpression attenuates Tpo-dependent BM-
derived megakaryocyte development by reducing mega-
karyocyte size and ploidy. The SH2 domain of Lnk is es-
sential for its inhibitory function in 32D cells and also in
primary BM cells. In vivo analysis recapitulated our results
using cell cultures; Lnk-deficient BM and spleen displayed
elevated numbers of megakaryocytes with increased ploidy.
In addition, Lnk-deficient BM or spleen-derived mega-
karyocytes displayed enhanced sensitivity to Tpo during in
vitro culture. This is shown to be a consequence of
enhanced STAT3, STAT5, Akt, and MAPK signaling
pathways in Lnk-deficient megakaryocytes after Tpo stim-
ulation. Thus, Lnk negatively modulates mpl signaling path-
ways and is important for Tpo-mediated megakaryocyto-
poiesis in vivo.
 
Materials and Methods
 
Mice, Cell Lines, and Media. 
 
Lnk-deficient mice were pro-
vided by Dr. T. Pawson (Samuel Lunenfeld Research Institute,
Toronto, Canada). Lnk nullizygous mice were backcrossed onto
the C57/BL6 background for seven generations. WT controls
were littermates or purchased from Jackson ImmunoResearch
Laboratories. IL-3–dependent 32D clone 3 cells were purchased
from the American Type Culture Collection. 32D cells were
maintained in RPMI 1640 containing 10% heat-inactivated FBS
(JRH Biosciences) and 10% WEHI-3B cell supernatant as a
source of IL-3 (WEHI media). Tpo growth media consisted of
RPMI 1640 containing 10% FBS supplemented with 1 ng/ml of
megakaryocytes growth and differentiation factor (MGDF). MGDF,
a pegylated and truncated human recombinant Tpo, was pro-
vided by Amgen, Inc.
 
Retroviral Constructs.
 
MSCV-IRES-GFP (MIG) vector was a
gift from Dr. K. Humphries (Terry Fox Laboratories, Vancouver,
Canada). pcDNA-Lnkwt, Lnk (R354E), and Lnk (Y536F) con-
structs were provided by Dr. S. Takaki (University of Tokyo, To-
kyo, Japan). Lnk cDNA was digested with BamHI and EcoRI,
and subsequently blunt-end ligated to the MIG vector linearized
by HpaI. The MIG-Lnk (W191A) construct was generated
through site-directed mutagenesis using the following oligos: 5
 
 
 
-
cagcaatggacagcggcgcacgcGCgcagcggggtcgcctggtgc-3
 
 
 
, and 5
 
 
 
-gca-
ccaggcgaccccgctgcGCgcgtgcgccgctgtccattgctg-3
 
 
 
 (Stratagene). 5
 
 
 
-
HA-tagged mpl was generated by PCR and inserted into the
EcoRI and XhoI sites of MSCV-PGKneo vector (CLONTECH
Laboratories, Inc.).
 
Retroviral Transduction.
 
3 
 
 
 
g of each retroviral construct was
cotransfected with 1 
 
 
 
g pCL-Eco (22) into one 100-cm plate of 
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50% confluent Phoenix packaging cells (provided by G. Nolan,
Stanford University, Stanford, CA), using Fugene 6 reagent
(Roche Applied Science). The resulting supernatant was col-
lected 48 h later. The viral titer was determined by serial dilution
of the viral supernatant and infection of 3T3 cells; 2–10 
 
 
 
 10
 
6
 
PFU/ml was routinely obtained. Supernatants with equal viral ti-
ters were used in each experiment. 32D/mpl cells or lineage neg-
ative (Lin
 
 
 
) BM cells (see Lin
 
 
 
 BM-derived Megakaryocyte Cul-
ture and Polylipid Analysis) were spin-infected with the desired
viral supernatant containing 10 
 
 
 
g/ml polybrene (Sigma-Aldrich)
at 2,000 revolutions/min (Sorvall RT7) for 1 h at 30
 
 
 
C.
 
Cell Proliferation Assay. 
 
To measure 32D cell proliferation,
we seeded triplicate samples of cells (200 
 
 
 
l/well; 2 
 
 
 
 10
 
5
 
/ml) in
96-well plates, and cultured them for 3 d with different concen-
trations of cytokines. We added 15 
 
 
 
l of 3-(4,5-dimethylthia-
zole-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT; Promega)
to each well and measured live cell numbers according to the
manufacturer’s instructions. Cell growth assays were performed
in 24-well plates with 1 ml of cells per well at a concentration of
2 
 
 
 
 10
 
5
 
 cells/ml. Every day a portion of the cells was removed
and counted in the presence of trypan blue to exclude dead cells.
 
Cell Cycle Analysis. 
 
2 d after retroviral transduction, 32D/
mpl cells were washed and switched to Tpo media. After over-
night culture, 1-ml aliquots of cells from each sample were incu-
bated at 37
 
 
 
C in the presence of 10 
 
 
 
g/ml Hoechst 33342
(Sigma-Aldrich) for 0.5 h. 2 
 
 
 
g/ml propidium iodide (PI) was
added, and the cells were subjected to flow cytometry using the
LSR II flow cytometer (BD Biosciences). Collected data were
analyzed using ModFit software (Verity Software).
 
Lin
 
 
 
 BM-derived Megakaryocyte Culture and Polyploidy Analysis.
 
8–12-wk-old C57Bl6/J or BALB/cJ mice obtained from The
Jackson Laboratory were used to isolate BM cells. BM cells from
the tibia and femurs were dissociated by passing through 18-
gauge needles and filtered through a 70-micron cell strainer. The
BM cells were labeled with a biotinylated cocktail of lineage-spe-
cific antibodies followed by a tetrameric antibody complex and
magnetic colloids (StemCell Technologies Inc.). Lin
 
 
 
 BM cells
were purified using a 0.3-inch StemStep column following the
manufacturer’s protocol (StemCell Technologies Inc.). Lin
 
 
 
 BM
cells were plated in 24-well tissue culture plates at 5 
 
 
 
 10
 
5
 
 cells/
well and spin-infected with desired viral supernatant for 1 h. Sub-
sequently, the Lin
 
 
 
 BM cells were allowed to expand and express
transduced genes by culturing in the following media: IMDM
containing 10% FBS, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin
and streptomycin, 50 
 
 
 
M 
 
 
 
-mercaptoethanol, 50 ng/ml SCF, 50
ng/ml Flt3 ligand, and 20 ng/ml IL-6 (PeproTech). 2 d later, the
GFP
 
 
 
 cells were purified using flow cytometric sorting, and
plated at 0.5 
 
 
 
 10
 
5
 
 cells/well in megakaryocyte culture media in
an eight-well chamber coverglass (Nunc). The megakaryocyte
culture media is composed of IMDM containing 1% Nutridoma-
SP (Roche Applied Science), 2 mM 
 
l
 
-glutamine, 100 U/ml pen-
icillin and streptomycin, and 50 
 
 
 
M 
 
 
 
-mercaptoethanol, supple-
mented with 50 ng/ml Tpo. 4 d later, the megakaryocytes were
imaged using a Nikon TE300 inverted microscope equipped
with a Hamamatsu Orca digital camera, and the images were ac-
quired using OpenLab software (Improvision). The sizes of the
megakaryocytes were manually measured in OpenLab; thousands
of megakaryocytes were manually measured in each group in
each experiment. Median cell sizes were obtained in each experi-
ment, and the mean of the cell size from at least three indepen-
dent experiments was calculated.
To determine ploidy, cultured megakaryocytes were labeled in
50 
 
 
 
g/ml PI in 0.1% sodium citrate solution (hypotonic PI)
overnight or longer, and subjected to flow cytometry using flow
cytometer FACSCalibur (BD Biosciences; reference 23).
 
Megakaryocyte Quantification and Culture. 
 
8–16-wk-old WT
and Lnk-deficient mice were killed by cervical dislocation. BM
and spleen cells were dissociated in CATCH buffer (Ca
 
2
 
 
 
 and
Mg
 
2
 
 
 
-free PBS containing 3.5% BSA, 1 mM adenosine, 2 mM
theophylline, and 0.38% sodium citrate), and passed through a
100-micron cell strainer. A portion of the cells was enumerated
in the presence of 3% acetic acid to exclude enucleated red blood
cells. The remaining cells were incubated with Fc blocker to
block nonspecific binding and stained with FITC–CD41 anti-
body (1:200; BD Biosciences). A small portion of the cells was
subjected to FACS analysis to measure the percentage of CD41
 
 
 
cells. The remaining cells were labeled with hypotonic PI solu-
tion as mentioned before. 50 
 
 
 
g/ml RNase A was added and in-
cubated at room temperature for 0.5 h before FACS analysis.
Cells from one femur and one tibia, or from a quarter of a spleen
were used from each mouse. All the cells were subjected to
FACS analysis, and CD41
 
 
 
 cells were gated for DNA content
analysis. Cells with DNA content 
 
 
 
8N were quantified. At least
four to six mice of each genotype were used.
For megakaryocyte culture, BM or spleen cells were dissoci-
ated in IMDM with 5% FBS. Total BM or spleen cells were enu-
merated, washed in serum-free media, and divided into five
groups. Each group of cells was cultured in the serum-free media
(as mentioned before) containing different concentrations of Tpo
(0, 0.1, 1, 10, and 50 ng/ml Tpo), at 10
 
6
 
 cells/ml. 4 d later, the
cells were harvested in CATCH buffer, and stained with FITC–
CD41 antibodies. The DNA were labeled with hypotonic-PI so-
lution and polyploidy were quantified as mentioned before.
These experiments were repeated independently four times.
The mean megakaryocytes ploidy was calculated according to
the following equation:
where 
 
n
 
p
 
 is the number of megakaryocytes in ploidy class 
 
p
 
 (
 
p
 
 
 
 
 
8, 16, 32, 64, 128), and 
 
n
 
 is the total number of megakaryocytes
in all ploidy classes (24).
 
Protein Lysates and Western Blot Analysis. 
 
After sorting 32D–
mpl cells for the GFP
 
 
 
 population expressing either vector alone
or a vector encoding Lnk, we allowed them to recover in WEHI
(IL-3) media overnight. Cells were starved in RPMI 1640 con-
taining 1% BSA for 4 h. We subsequently stimulated the cells
with 20 ng/ml Tpo for 0, 10, 30, and 120 min, and directly lysed
them in SDS sample buffer (BioRad Laboratories) (100 
 
 
 
l lysis
buffer per 10
 
6
 
 cells). The samples were Western blotted with the
indicated antibodies: anti-STAT5 (C-17) antibody (1:500; Santa
Cruz Biotechnology, Inc.), anti–p-STAT5 (pTyr 694), p-STAT3
(pTyr 705), STAT3, p-MAPK (pThr202/Tyr204), and p42/44
MAPK antibody (1:1,000, Cell Signaling Technology).
BM cells were labeled with FITC–CD41, and CD41
 
 
 
 mega-
karyocytes were sorted using a MoFlo high-speed sorter. In time
course studies, megakaryocytes were labeled with FITC–CD41
and first purified by EasyStep magnetic beads (StemCell Technol-
ogies), and further purified by flow cytometric sorting. Purified
CD41
 
 
 
 cells were starved in IMDM with 1% BSA for 1–2 h, and
stimulated with 1 or 10 ng/ml Tpo for 10 min in IMDM plus
0.1% BSA. Time course studies were performed in the presence
mean megakaryocytes ploidy anti log2
log2
p 8 =
128
∑
⎝⎠
⎜⎟
⎛⎞
p () np ×
n
------------------------------------------ , – = 
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of 10 ng/ml Tpo for 0, 10, 30, 60, and 120 min. Equal numbers
of cells (2–3 
 
 
 
 10
 
5
 
) were used for each time point. The protein
lysates were resolved on NuPAGE Novex Bis-Tris gels and
Western blotted with anti-pAkt (Ser 473) or Akt (Cell Signaling
Technology), or STAT5 and p42/44 MAPK antibodies as de-
scribed before. These experiments were performed indepen-
dently three to five times.
 
Results
 
The Lnk SH2 Domain Is Required for Inhibiting the Growth
of 32D Cells Expressing mpl.
 
IL-3–dependent 32D he-
matopoietic cells were used to establish a stable cell line ex-
pressing the Tpo receptor (mpl), designated as 32D–mpl.
Although the parental cells did not respond to Tpo, 32D–
mpl cells proliferated in a dose-dependent manner with
maximal growth at 1–10 ng/ml Tpo (Fig. 1 a). At those
concentrations, Tpo-induced cell proliferation was as ro-
bust as that of IL-3. Therefore, we used 1 ng/ml Tpo as the
optimal concentration in all subsequent experiments.
The effect of Lnk in Tpo-dependent 32D cell growth was
examined by overexpression of WT Lnk using the MIG
vector. MIG is a bicistronic vector containing GFP down-
stream of an IRES. As GFP expression is tightly correlated
with the expression of the gene cloned upstream of the
IRES (25), we were able to identify cells expressing Lnk by
analyzing GFP fluorescence. We introduced either vector
alone or Lnk into 32D/mpl cells and determined the frac-
tion of GFP
 
 
 
 infected cells 2 d later. We measured the
GFP
 
 
 
 fraction every 3 d, as the cells divide, relative to that
2 d after infection (Fig. 1 b). When the cells were grown in
Tpo, the Lnk expressing fraction was dramatically reduced
to 20% after 3 d and to 3% after 6 d, whereas the fraction of
control vector-expressing GFP
 
 
 
 cells was unchanged (100%)
over the 9-d experiment. Lnk expression also inhibited cell
growth in the presence of IL-3, but to a lesser extent (Fig. 1
b). To confirm that Lnk overexpression blocked cell prolif-
eration, cell numbers of vector-expressing and Lnk-express-
ing cells were counted and calculated daily. As shown in Fig.
1 c, Lnk expressing 32D–mpl cells did not increase in num-
ber, whereas the vector control cells exhibited exponential
growth. Lnk did not inhibit the growth of nonhematopoi-
etic cell lines, such as 3T3 or 293T cells, indicating that Lnk
is not toxic to most cell lines (unpublished data).
Next, we set out to study whether Lnk inhibits the cell
cycle, and if so, at which stage. 2 d after infecting 32D–mpl
cells with MIG vector alone or MIG-Lnk, we plated them
in Tpo media. After overnight culture, portions of cells from
both groups were subjected to cell cycle analysis. GFP
 
 
 
cells expressing vector alone grew exponentially, demon-
strating a cell cycle profile of 47% S-phase, 44% G1, and
9% G2/M phase (Fig. 1 d, left). In contrast, GFP
 
 
 
 cells ex-
pressing Lnk showed a markedly decreased S-phase popula-
tion (16%), and an increased proportion of G1 (61%) and
G2/M (23%) cells (Fig. 1 d, right). Therefore, overexpres-
sion of Lnk blocked S-phase progression, and led to accu-
mulation of the cells in the G1 and G2/M phases.
To investigate the importance of different domains of
Lnk in growth inhibition, we generated point mutations in
Figure 1. Lnk inhibits 32D
cell growth via blocking S-phase
progression, and the SH2 domain
of Lnk is essential for its inhibi-
tory function. (a) Establishment of
mpl-expressing 32D cells. Paren-
tal 32D cells and cells stably ex-
pressing mpl were cultured in
IL-3 or different concentrations
of Tpo. Live cell numbers in the
presence of Tpo relative to that
in IL-3 after 3 d of culture were
determined by MTT absorbance.
(b) Overexpression of Lnk in
32D/mpl cells inhibits cell growth
in response to Tpo. We intro-
duced either vector alone or WT
Lnk into 32D/mpl cells and deter-
mined the proportion of infected
cells as those that express GFP 2 d
later. We measured the GFP 
fraction every 3 d, and the per-
centage of GFP  cells relative to
the infection rate 2 d after infec-
tion was plotted. Results are rep-
resentative of more than five in-
dependent experiments. (c) 2 d
after the infection, total cell numbers were counted and GFP  percentages were determined daily. The numbers of vector- or Lnk-expressing GFP 
cells were calculated and plotted (mean   SD). (d) Cells infected with either vector alone or Lnk were subjected to cell cycle analysis after overnight cul-
ture in the presence of Tpo; only GFP  cells were gated in both plots. Results are representative of three independent experiments. (e) We introduced
the WT or the mutant Lnk cDNA constructs into 32D/mpl cells and measured the GFP  fraction every 3 d as described in b. The cells were maintained
in the presence of 1 ng/ml Tpo, and the percentage of GFP  cells relative to the infection rate 2 d after infection was plotted. Results are representative
of more than three independent experiments. 
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the Lnk cDNA to ablate individual domains and overex-
pressed these mutant forms of Lnk in 32D–mpl cells (Fig. 1
e). When cultured in the presence of 1 ng/ml Tpo, the
fraction of cells expressing WT Lnk became reduced dra-
matically, whereas mutation of the SH2 domain Lnk (Lnk
R364E) completely abolished the inhibitory function of
Lnk on cell proliferation (Fig. 1 e). In contrast, mutation of
the conserved tyrosine at the COOH terminus (Y536F)
did not affect Lnk’s inhibitory function (Fig. 1 e). The PH
domain mutation (W191A) of Lnk moderately compro-
mised the inhibitory function of Lnk (Fig. 1 e).
These findings indicate the SH2 domain of Lnk is essential
for its inhibitory function, whereas the PH domain plays a
minor role and the conserved tyrosine at the COOH termi-
nus is dispensable for this Lnk-dependent function.
 
The SH2 Domain of Lnk Is Essential for Inhibiting the Sustained
Activation of STAT5 and p42/44 MAPK Induced by Tpo.
 
To
investigate the mechanism by which Lnk inhibits 32D cell
proliferation, we studied the activation of downstream sig-
naling molecules. By flow cytometry, we purified 32D–
mpl cells transduced with the vector alone or WT Lnk or
Lnk mutants, and subjected them to Western blotting anal-
ysis after Tpo stimulation. In vector-transduced 32D/mpl
cells, Tpo induced maximal STAT5 phosphorylation at 10
min, and the level of phosphorylated STAT5 slowly
dropped to 30% at 30 min, and 15% at 120 min (Fig. 2 a,
lanes 1–4). In Lnk-transduced cells, Tpo activated maximal
STAT5 phosphorylation at 10 min to a level similar to that
in control cells; however, the level of phosphorylated
STAT5 dropped rapidly thereafter, with 15% remaining at
30 min and only 4% at 120 min (Fig. 2 a, lanes 5–8).
Similarly, in control cells, Tpo activated maximal p42/
44MAPK phosphorylation at 10–30 min, and the level of
phosphorylated MAPK slowly dropped to 50% of the max-
imum at 120 min (Fig. 2 b, lanes 1–4). Lnk expression only
moderately attenuated maximal activation of MAPK (60%
of the control cells) at 10 min. However, Lnk inhibited
prolonged activation of p44/42MAPK induced by Tpo,
resulting in undetectable levels of MAPK activation at 120
min (Fig. 2 b, lanes 5–8). Total STAT5 or MAPK protein
levels were unaffected (Fig. 2, bottom). Thus, overexpres-
sion of Lnk attenuated the prolongation of STAT5 and
MAPK phosphorylation induced by Tpo.
Fig. 2 also shows that the Lnk SH2 domain is essential
for Lnk inhibition of STAT5 and MAPK activation. Lnk
(R364E)-transduced cells showed similar STAT5 activation
kinetics to vector controls (Fig. 2 a, lanes 9–12). In con-
trast, Lnk (W191A) and Lnk (Y536F)-transduced cells at-
tenuated prolonged activation of STAT5 to a similar extent
as seen in WT Lnk-transduced cells (Fig. 2 a, lanes 13–20).
Similar to the inhibition of sustained STAT5 activation,
Lnk inhibited sustained MAPK activation induced by Tpo
(Fig. 2 b, lanes 1–8). The R364E mutation abolished Lnk
inhibition of prolonged MAPK activation (Fig. 2 b, lanes
9–12), whereas the W191A and Y536F mutations did not
affect Lnk inhibitory function (Fig. 2 b, lanes 13–20).
Thus, the SH2 domain of Lnk is essential for inhibiting mpl
signaling in 32D cells, whereas neither the phosphorolat-
able tyrosine at the COOH terminus nor the PH domain is
essential for these inhibitory functions of Lnk.
 
The SH2 Domain of Lnk Is Required to Reduce the Growth,
Size, and Ploidy of BM-derived Megakaryocytes.
 
To study
Lnk function in Tpo/mpl signaling in primary cells, we an-
alyzed BM-derived megakaryocytes. Lin
 
 
 
 hematopoietic
progenitor BM cells were infected either with MIG vector
or MIG-Lnk, and GFP
 
 
 
 cells were purified by flow cytom-
etry and equal numbers of cells were plated onto cover-
glasses in serum-free medium containing Tpo as the only
Figure 2. The SH2 domain of Lnk is
critical for inhibiting sustained STAT5 and
p42/44 MAPK phosphorylation induced by
Tpo. 32D/mpl cells infected with either
vector alone or the WT or the mutant
forms of Lnk were purified, stimulated with
Tpo, and lysed at indicated intervals followed
by Western blotting analysis. (a) STAT5
phosphorylation and protein levels after
Tpo administration. The triangles indicate
the 120-min time points. (b) P42/44 MAPK
phosphorylation and protein levels after
Tpo administration. White lines indicate
that intervening lanes have been spliced out.
Representatives of three independent ex-
periments are shown. 
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cytokine. 3–4 d later, the megakaryocytes were imaged
(Fig. 3 b) and cell sizes were quantified (Fig. 3 a). Lnk ex-
pression reduced megakaryocyte size to 
 
 
 
60% of vector-
transduced controls (19 
 
 
 
m vs. 33 
 
 
 
m; Fig. 3 a). However,
they both displayed similar gross morphologies examined by
light microscopy (Fig. 3 b). Most nonmegakaryocytes that
did not respond to Tpo were condensed and dead by the
end of 4 d of culture (double-lined arrows); only large
megakaryocytes were apparent (Fig. 3 b). White arrows in-
dicate immature megakaryocytes with a smooth cell mem-
brane before extensive changes in morphology; short wide
arrows point to megakaryocytes beginning to undergo cell
membrane and cytoplasmic maturation; and long thin ar-
rows indicate mature megakaryocytes that have undergone
advanced stages of cytoplasmic maturation (Fig. 3 b). There-
fore, Lnk overexpression reduced megakaryocyte sizes with-
out grossly blocking cytoplasmic morphology changes.
Megakaryocyte size often correlates with DNA content;
therefore, we analyzed the ploidy of the megakaryocytes
derived from these BM cultures. We considered megakary-
ocytes to be those cells with DNA content exceeding
4N. Lnk overexpression reduced megakaryocyte numbers,
causing a 37 
 
 
 
 5% reduction in the number of cells with
DNA content of 8N and greater. Megakaryocytes derived
from vector-transduced Lin
 
 
 
 BM cells showed an array of
DNA distribution, with 16N (39%) and 32N (41%) being
the most predominant populations, and 8N (15%) and 64N
(6%) as minor ones (Fig. 3 c). Megakaryocytes derived
from the Lnk-transduced Lin
 
 
 
 BM culture exhibited a dra-
matic decrease in DNA ploidy. The most predominant
populations were 8N (50%) and 16N (44%), whereas the
32N (6%) population was minor and the 64N (
 
 
 
1%) peak
was almost invisible (Fig. 3 d). Therefore, Lnk overexpres-
sion in primary Lin
 
 
 
 BM cells reduced both megakaryo-
cyte number and ploidy.
Next, we examined the individual domains of Lnk re-
sponsible for reducing megakaryocyte size and ploidy. The
SH2 domain mutant that abolished Lnk function in 32D
cells, R364E, did not affect megakaryocyte size or ploidy
when overexpressed in Lin  BM cells (Fig. 3, a and f). In
contrast, overexpression of Lnk (Y536F) reduced mega-
karyocyte size and ploidy to a similar extent as WT Lnk
(Fig. 3, a and g). Consistently, the PH domain mutation
(W191A) moderately affected Lnk function in reducing
megakaryocyte size and ploidy (Fig. 3, a and e). Thus, the
SH2 domain of Lnk is crucial for reducing Tpo-mediated
megakaryocyte development, whereas the PH domain and
conserved tyrosine are not essential for Lnk-mediated inhi-
bition of Tpo signaling.
Increased BM and Splenic Megakaryocyte Numbers and Ploidy
in Lnk Nullizygous Mice. Both BM and spleens of Lnk-
deficient mice possess increased numbers of megakaryocytes.
To investigate megakaryocytopoiesis in Lnk-deficient mice,
first we analyzed both in BM and spleen the total number of
megakaryocytes as well as the number of mature megakary-
ocytes with  8N ploidy (Table I and Fig. 4). CD41, also
called glycoprotein IIb, is expressed in all megakaryocytes
with DNA contents form 2N to 128N, and is commonly
Figure 3. The SH2 domain of Lnk is required to reduce the size and
ploidy of megakaryocytes. Lin  BM cells were transduced with either
vector alone, or with WT or mutant forms of Lnk, and GFP  cells were
purified and cultured in serum-free media containing only Tpo (see
Materials and Methods). After 4 d of growth and differentiation, the di-
ameters of the megakaryocytes were measured and the median diameters
( SD) are shown in a. Student’s t tests were performed on each form of
Lnk compared to the vector control, and p-values are shown on the top
of each bar. (b) Differential interference contrast images of megakaryo-
cytes derived from vector-transduced Lin  progenitor cells (left) and
megakaryocytes expressing Lnk (right). White arrows, long thin arrows,
and short wide arrows indicate megakaryocytes at different developmental
stages (see Results). Double-lined arrows point to dead cells that do not
respond to Tpo. Bar, 50  m. (c–g) Ploidy analysis of the megakaryocytes
derived from vector-transduced (c), Lnk-transduced (d), Lnk (W191A)-
transduced (e), Lnk (R364E)-transduced (f), and Lnk (Y536F)-transduced
(g) Lin  BM cells. GFP  cells were gated, and cells with 8N and greater
ploidy were analyzed.Tong and Lodish 575
used as a megakaryocyte marker. Thus, we determined total
megakaryocyte numbers by quantifying cells expressing the
CD41 surface marker. We also quantified mature mega-
karyocytes as those that are CD41  and have 8N or greater
ploidy. As shown in Table I, in Lnk-deficient mice total
BM cells are only slightly increased in number (30%, line 1),
whereas the percentage of CD41  megakaryocytes in-
creased twofold (line 2). Mature megakaryocytes with 8N
and greater ploidy increased 2.6-fold, compared with age-
and sex-matched WT controls (line 3). Spleens from Lnk-
deficient animals displayed more profound differences than
did BM. Although the total number of spleen cells in Lnk-
deficient mice increased approximately twofold (line 4), the
total number of CD41  megakaryocytes increased fivefold
(line 5). Remarkably, the number of mature megakaryo-
cytes in the spleen increased 10-fold compared with WT
controls (Line 6). Therefore, Lnk-deficient BM and spleens
had increased numbers of megakaryocytes and proportion-
ally more mature megakaryocytes ( 8N) compared with
WT controls.
We further investigated the ploidy distribution of mature
megakaryocytes (Fig. 4). Lnk-deficient megakaryocytes ex-
hibited a higher ploidy distribution than WT controls.
Compared with WT BM, Lnk-deficient BM had a lower
percentage of megakaryocytes with low ploidy (8N and
16N), whereas the percentages of cells with high ploidy
(32N and 64N) doubled (Fig. 4 c). The mean ploidy of
Lnk-deficient BM megakaryocytes increased to 18N, com-
pared with 15N for WT counterparts (Fig. 4 c). Lnk-defi-
cient spleens also exhibited an array of megakaryocytes
with different DNA contents, however, WT spleens con-
tained too few mature megakaryocytes ( 8N) to be quan-
tified (unpublished data).
Enhanced Sensitivity to Tpo in Lnk-deficient Megakaryocyte
Culture. Because Tpo is the most important cytokine reg-
ulating megakaryocytopoiesis and is involved in every step
Figure 4. Increased megakaryocyte ploidy
in Lnk nullizygous mice. CD41  megakary-
ocytes from WT BM (a) and Lnk-deficient
BM (b) were analyzed for DNA content.
Only mature megakaryocytes with 8N and
greater ploidy are shown. (c) Quantification
of the percentages of individual ploidy classes
( 8N) of BM megakaryocytes (mean  
SD). Mean ploidy was calculated as stated in
Materials and Methods. Student’s t test was
performed. P   0.001.
Table I. CD41  Megakaryocytes from the BM and Spleens of WT and Lnk Nullizygous Mice
Line Genotype WT Lnk Fold increasea
1 Total BM cells per mouse 58   9   106 78   10   106 1.3 (P   0.01)
2 Percentage of CD41  cells in BM 1.1   0.2% 2.2   0.5% 2.0 (P   0.005)
3 Megakaryocytes per BM (CD41 ,  8N) 25   7   103 66   24   103 2.6 (P   0.01)
4 Total spleen cells per mouse 173   27   106 345   76   106 2.0 (P   0.001)
5 Percentage of CD41  cells in spleen 2.1   0.5% 10.7   2.4% 5.1 (P   0.005)
6 Megakaryocytes per spleen (CD41 ,  8N) 4.3   0.5   103 45   6   103 10 (P   0.0005)
8–16-wk-old mice were used to isolate BM and spleen cells. Total BM and spleen cell numbers (mean   SD) were enumerated by hemoctocytometer
counting. Percentages of CD41  cells (mean   SD) were determined by flow cytometry. The numbers of CD41  megakaryocytes with 8N and
greater ploidy were determined by flow cytometry.
aStudent’s t test was performed, and the p-values from each group are shown.Lnk Regulates Megakaryocytopoiesis 576
of this process, we investigated whether Lnk is a physio-
logical inhibitor of Tpo-dependent megakaryocytopoiesis.
Increases in megakaryocyte number result from cell prolif-
eration (mitosis), whereas polyploidy is a result of endomi-
tosis, a process that is characterized by continued DNA
replication in the absence of cytokinesis (26). To assess
megakaryocyte proliferation and endomitosis in response
to Tpo, we cultured BM and spleen cells in serum-free
media with Tpo as the only cytokine. As shown in Fig. 5,
Tpo stimulated megakaryocyte production in a dose-
dependent manner, reaching maximal levels at 10–50 ng/
ml Tpo. The number of CD41  megakaryocytes with 8N
and greater ploidy derived from WT BM cultures increased
1.6-fold at the maximal Tpo concentration (Fig. 5 a). In
contrast, the number of megakaryocytes derived from Lnk-
deficient BM increased nearly threefold in the presence of
Tpo (Fig. 5 a). This resulted in fivefold more megakaryo-
cytes produced at high Tpo concentrations (50 ng/ml), rel-
ative to WT BM. Similarly, spleen cultures from WT mice
exhibited a minimal increase in megakaryocyte production
(1.5-fold induction) in response to Tpo. In contrast, the
number of megakaryocytes derived from Lnk-deficient
spleen cultures increased threefold (Fig. 5 b). This led to a
16-fold increase in megakaryocyte production in the pres-
ence of high concentration of Tpo (50 ng/ml), compared
with WT spleen cells. These data indicate that the absence
of Lnk enhanced the proliferation of megakaryocytes in re-
sponse to Tpo.
During in vitro culture Tpo, in a dose-dependent man-
ner, induces megakaryocyte proliferation and maturation
and increases megakaryocyte ploidy. As shown in Fig. 5 c,
Tpo increased megakaryocyte ploidy in both WT and Lnk-
deficient BM cells. Importantly, Lnk-deficient megakaryo-
cytes showed a higher ploidy than WT controls at all Tpo
concentrations (Fig. 5 c). Interestingly, in the presence of a
maximal Tpo concentration (50 ng/ml), the difference of
megakaryocyte ploidy between these two groups was not
statistically significant (Fig. 5 c). Similarly, in the megakary-
ocyte culture derived from Lnk-deficient spleens, Tpo also
increased megakaryocyte ploidy (unpublished data). How-
ever, cultures from WT spleens generated insufficient
numbers of megakaryocytes to determine the ploidy.
Enhanced Tpo/mpl Signaling Pathways in Lnk-deficient
Megakaryocytes. To investigate the mechanism by which
Lnk deficiency enhances Tpo-dependent megakaryocyto-
poiesis, we used purified CD41  megakaryocytes and mea-
sured the four following signaling pathways induced by
Tpo after 10 min of stimulation: p44/42MAPK, Akt,
STAT 3, and STAT5 (Fig. 6, a–c). The absence of Lnk en-
hanced the extent of activation of all four signaling mole-
cules stimulated by either 1 or 10 ng/ml Tpo (Fig. 6, a–c,
top). As expected, the total levels of these signaling proteins
remained similar (Fig. 6, a–c, bottom). Therefore, Lnk-
deficient megakaryocytes displayed enhanced activation of
four major signaling pathways induced by Tpo.
To investigate whether Lnk deficiency causes alterations
in the kinetics of Tpo-induced signaling pathways, we an-
alyzed the duration of Akt and MAPK activation after Tpo
stimulation. In WT megakaryocytes, 10 ng/ml Tpo in-
duced maximal Akt phosphorylation at 10 min and the
level of Akt phosphorylation was down-regulated by 60
min. In contrast, Lnk-deficient megakaryocytes showed
sustained Akt activation for at least 60 min (Fig. 6 d, top).
Similarly, in WT megakaryocytes Tpo induced maximal
p44/42MAPK phosphorylation at 10 min, and activation
declined thereafter (Fig. 6 e, top). In contrast, Lnk-defi-
cient megakaryocytes exhibited prolonged activation of
MAPK for as long as 120 min (Fig. 6 e, top). The total
levels of these signaling proteins remained similar (Fig. 6,
d and e, bottom). Therefore, the absence of Lnk caused
enhanced and prolonged activation of Tpo-induced sig-
naling pathways.
Figure 5. Enhanced megakaryocyte growth and ploidy in response to
Tpo during in vitro megakaryocyte culture. Total BM (a) or spleen (b) cells
from WT mice or Lnk nullizygous mice were cultured in different concen-
trations of Tpo for 4 d, the numbers of CD41  megakaryocytes with 8N
and greater ploidy were enumerated (mean   SD). (c) Mean ploidies
( SD) of BM-derived megakaryocytes were plotted. A Student’s t test was
performed, and p-values are shown on top of each pair of points.Tong and Lodish 577
Discussion
Lnk Is a Physiological Negative Regulator of Tpo-mediated
Signaling and Megakaryocytopoiesis. Our most important
result is that physiological levels of the adaptor protein Lnk
negatively regulate Tpo-mediated signaling both for mega-
karyocyte proliferation and endomitosis. This was evidenced
by our finding that both BM and spleen of Lnk-deficient
mice contained increased total numbers of megakaryocytes
that had a significantly increased ploidy, compared with
WT mice. In addition, Lnk-deficient megakaryocytes de-
rived from both BM and spleen showed enhanced sensitiv-
ity to Tpo during in vitro culture. A principal, if not the
only, action of Lnk is direct inhibition of mpl signal trans-
duction because, after Tpo administration, CD41  mega-
karyocytes from Lnk-deficient mice exhibited increased ac-
tivation of STAT3, STAT5, Akt, and MAPK proteins, as
well as prolonged activation of the two signaling proteins
we tested, MAPK and Akt.
Conversely, we showed that Lnk overexpression nega-
tively regulates Tpo-mediated cell proliferation in hemato-
poietic cell lines by attenuating Tpo-induced S-phase pro-
gression and causing cells to accumulate in the G1 and
G2/M stages. In addition, Lnk overexpression decreased
Tpo-dependent megakaryocyte numbers and ploidy in
BM-derived megakaryocyte cultures. In parallel, we showed
that Lnk overexpression reduces the duration of activation
of STAT5 and MAPK signaling proteins. Together, our
work establishes that the level of Lnk protein tightly regu-
lates signal transduction by the mpl receptor protein and,
thus, both the number and ploidy of megakaryocytes.
Regulation of Cytokine Receptor Signaling by the Lnk Family
of Adaptor Proteins. Negative regulators of receptor signal-
ing are important for quantitatively controlling a cell’s in-
trinsic sensitivity to cytokines. As examples, protein tyrosine
phosphatase SHP-1 docks to phosphorylated erythropoi-
etin receptor, resulting in dephosphorylation of JAK2 (27).
The SH2-containing inositol-5-phosphatase inactivates the
phosphoinositide 3-kinase–Akt pathway (28). Several sup-
pressor of cytokine signaling proteins are induced by JAK–
STAT pathways upon cytokine stimulation, and act within
a classical negative feedback loop both to inhibit activation
of signaling pathways and to target signaling components
for proteasomal degradation (29, 30). As a result, loss of
these negative regulators causes elevated and prolonged sig-
naling to multiple cytokines.
The Lnk family of adaptor proteins is structurally distinct
from the aforementioned negative regulators in that they
do not possess any enzymatic activity. We found that, in
32D–mpl cells, overexpression of Lnk does not significantly
inhibit the initial activation of mpl-mediated signaling
pathways such as STAT5 or p42/44MAPK. Rather, Lnk
diminishes the time these pathways remain active after a
single application of a high concentration of Tpo to cy-
tokine-deprived cells. Consistent with this finding, we
showed that loss of Lnk enhances four Tpo-induced signal-
ing pathways (STAT3, STAT5, MAPK, and Akt) in
CD41  megakaryocytes. In addition, loss of Lnk prolongs
the activation of the two signaling pathways tested (MAPK
and Akt) in CD41  megakaryocytes. Similarly, BM-derived
mast cells from Lnk    mice show prolonged activation of
MAPK in response to IL-3 or SCF, compared with WT
controls (21).
We found that in both hematopoietic cell lines and
megakaryocyte progenitors, the SH2 domain of Lnk is es-
sential for Lnk’s function. Overexpression of an SH2 mu-
tant Lnk does not inhibit mpl signaling either in 32D–mpl
cells or Tpo-mediated megakaryocytopoiesis. Similarly, this
SH2 domain mutation abolishes the binding of Lnk to
c-Kit upon stimulation with SCF, leading to loss of Lnk-
Figure 6. Enhanced Tpo-induced
signaling pathways in Lnk-deficient
megakaryocytes. (a–c) CD41  BM
megakaryocytes from WT mice or
Lnk nullizygous mice were stimu-
lated with 0, 1, or 10 ng/ml of Tpo
for 10 min. Protein lysates from
equal numbers of cells were sub-
jected to Western blotting analysis.
Phosphorylation and total protein
levels of p42/44MAPK and Akt (a),
STAT5 (b), and STAT3 (c) are
shown. (d and e) Purified CD41  BM
megakaryocytes from WT mice or
Lnk nullizygous mice were stimulated
with 10 ng/ml of Tpo, and lysed at in-
dicated intervals followed by Western
blotting analysis. Phosphorylation and
total protein levels of Akt (d) and p42/
44MAPK (e) are shown.Lnk Regulates Megakaryocytopoiesis 578
dependent inhibition of hematopoietic cell development in
AGM culture (20). The conserved tyrosine near the
COOH terminus of Lnk, Y536, is phosphorylated by c-Kit
upon SCF binding. However, transgenic animals express-
ing Lnk Y536F under the control of lymphocyte-specific
promoters reveal that this tyrosine is dispensable for the
negative regulatory roles of Lnk in lymphocyte develop-
ment (31). In agreement, we found that Y536 is not im-
portant for Lnk’s function in modulating Tpo-dependent
32D cell proliferation or megakaryocyte development. In-
terestingly, the PH domain of Lnk is important, but not re-
quired, for inhibiting 32D cell growth or Tpo-mediated
megakaryocytopoiesis, whereas it is dispensable for inhibit-
ing hematopoietic differentiation in AGM culture (20).
Together, these findings suggest that one or more tyrosine-
phosphorylated proteins interact with the Lnk SH2 domain
and are crucial for Lnk inhibitory functions. The fact that
loss of Lnk enhances four Tpo-induced signaling pathways
(STAT3, STAT5, MAPK, and Akt) in CD41  megakaryo-
cytes suggests that Lnk may inhibit JAK2 activation or mpl
phosphorylation. We are currently investigating whether
Lnk directly binds to phosphotyrosines in mpl or JAK2,
whether this affects JAK2 kinase activity, and whether this
is part of the mechanism by which Lnk down-regulated
downstream signaling pathways.
Regulation of Hematopoiesis by Lnk. Among mice nullizy-
gous for Lnk family members, Lnk-deficient mice show the
most profound perturbation in hematopoiesis. In addition
to abnormal expansion of immature B cells (18) and en-
hanced stem cell repopulating activity (19), Lnk-deficient
animals exhibit elevated platelet numbers in the peripheral
blood, and increased numbers of CFU-megakaryocyte
progenitors in the BM and spleen (21). Here, we found
that BM and spleen of Lnk-deficient mice display an ab-
normal accumulation of both total CD41  megakaryocytes
and mature megakaryocytes with 8N or greater ploidy.
The latter phenotype is more profound in the spleen (10-
fold increase in cell number) than the BM (2.6-fold in-
crease). The extensive extramedullary hematopoiesis ob-
served in Lnk-deficient mice includes abnormal expansion
of erythroid cells and B lymphocytes, as well as megakary-
ocytes in the spleen. Thus, Lnk likely regulates signaling
by multiple cytokine receptors in multiple types of he-
matopoietic cells.
Megakaryocyte lineage commitment, CFU-megakaryo-
cyte and megakaryocyte proliferation, megakaryocyte poly-
ploidization, cytoplasmic maturation, and platelet frag-
mentation are related but separable processes. Through
mutagenesis in mice many genes have been found to be
important for various steps of megakaryocyte and platelet
development (32). Polyploidization, uniquely occurring
during megakaryocyte maturation, results from endomito-
sis; that is, continued DNA replication in the absence of
cytokinesis (26). Megakaryocyte proliferation (mitosis) and
differentiation (endomitosis) are separable processes, though
both are dependent on Tpo. Exogenous expression of the
c-myc oncogene drives overproduction of megakaryocytes
with decreased ploidy (33), indicating that c-myc is impor-
tant for megakaryocyte proliferation, but not endomitosis.
In contrast, transgenic mice overexpressing cyclin D3 dis-
play large megakaryocytes with high ploidy (34), whereas
antisense oligonucleotides to cyclin D3 inhibit megakaryo-
cytic endomitosis in BM culture (35). MAPK also is im-
portant for megakaryocyte endomitosis (16); MAPK is also
localized in the platelet-yielding demarcation membrane
system (36), suggesting it may be also involved in platelet
release.
Many cytokines regulate aspects of the complex mega-
karyocyte development process, including IL-3, -6, -11,
SCF, LIF, and erythropoietin (1). However, Tpo is the
major physiological regulator of megakaryocytopoiesis and
thrombopoiesis (1). Tpo alone can promote normal mega-
karyocyte development and platelet formation in vitro
from CD34  stem cells (37). Thus, our studies have fo-
cused on the modulation of Tpo-mediated hematopoiesis
by overexpression or loss of Lnk. Overexpression of Lnk in
primary BM cells cultured in the presence of Tpo leads to
reduced megakaryocyte numbers, sizes, and ploidy. Using
in vitro BM and spleen cultures, we demonstrated that loss
of Lnk renders megakaryocytes hypersensitive to Tpo, re-
flected in augmented proliferation and polyploidization.
Consistent with this finding, lack of Lnk causes elevated
megakaryocyte numbers and ploidy both in the BM and
spleen. Therefore, Lnk attenuates Tpo-induced cell prolif-
eration and endomitosis.
We found that overexpression of Lnk in primary BM
progenitor cells inhibits megakaryocyte proliferation, re-
sulting in smaller numbers of megakaryocytes. Lnk also in-
hibits endomitosis, thereby decreasing the extent of poly-
ploidization. Consistent with this data, Lnk overexpression
attenuates sustained activation of MAPK induced by Tpo
in 32D cells, and Lnk-deficient megakaryocytes exhibit en-
hanced Tpo-induced MAPK activation. Further experi-
ments are required to address whether Lnk inhibition of
Tpo-induced mitosis and endomitosis is mediated through
MAPK and/or cyclin D3.
Together, our data show that Lnk is a physiological neg-
ative regulator for Tpo-mediated megakaryocytopoiesis.
Although overexpression of Lnk reduces the number and
ploidy of megakaryocytes, their morphology appears grossly
normal, and the fact that Lnk-deficient mice have func-
tional platelets indicates that Lnk may not qualitatively af-
fect platelet formation. Because Tpo is also not essential for
megakaryocyte cytoplasmic maturation or platelet forma-
tion, this result suggests that Lnk acts in megakaryocytes
primarily by restricting mpl signaling. Interestingly, Lnk
heterozygous (Lnk   ) mice display a phenotype interme-
diate between that of Lnk homozygous (Lnk   ) mice and
WT mice (reference 21 and unpublished data), suggesting
that Lnk protein level is tightly regulated and critical for its
function in regulating cytokine receptor signaling.
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